Patients (n = 90)
Patient demographics
  Median age, years (range) 50 (18–86)
  Men 39 (43%)
  Women 51 (57%)
Exposure history
  Exposure to Wuhan or infected patient 86 (96%)
  Unknown exposure 4 (4%)
Comorbid conditions
  Any 45 (50%)
  Hypertension 17 (19%)
  Diabetes 5 (6%)
  Cardiovascular disease 3 (3%)
  Chronic obstructive pulmonary disease 1 (1%)
  Tuberculosis 2 (2%)
  Malignancy 2 (2%)
  Others 15 (17%)
Signs and symptoms
  Fever 70 (78%)
  Cough 57 (63%)
  Sputum production 11 (12%)
  Fatigue weakness 19 (21%)
  Myalgia 25 (28%)
  Sore throat 23 (26%)
  Chills 6 (7%)
  Headache 4 (4%)
  Diarrhea 5 (6%)
  Nausea 5 (6%)
  Vomit 2 (2%)
  No obvious symptoms 6 (7%)
Laboratory test
  C-reactive protein (mg/L; normal range 0–10)
    Increased 38 (42%)
    Decreased
    Normal 0 (0%)
52 (58%)
  Leucocytes (×109/L, normal range 3.5–9.5)
    Increased 3 (3%)
    Decreased 19 (21%)
    Normal 68 (76%)
  Positive for (SARS-CoV-2) nucleic acid test by
  Real-time PCR 90 (100%)